Korsgren O

Ga-68-Labeled Affibody Molecule-Based Radiopharmaceutical Targeting Platelet Derived Growth Factor Receptor Beta for Detection of Active Fibrosis in Patients with Myocardial Infarction.

Velikyan I, Grinnemo KH, Flodin V, ..., Korsgren O, Eriksson O

Pharmaceuticals (Basel, Switzerland) 18 (12) - [2025-12-01; online 2025-12-01]

Olof Eriksson SciLifeLab Fellow

[18F]MK-7246 for Positron Emission Tomography Imaging of the Beta-Cell Surface Marker GPR44.

Cheung P, Amin MA, Zhang B, ..., Odell LR, Eriksson O

Pharmaceutics 15 (2) - [2023-02-02; online 2023-02-02]

Olof Eriksson SciLifeLab Fellow

A new animal model signifying a decisive bridge between innate immunity and the pathognomonic morphological characteristics of Type 1 Diabetes

Angie T, Sofie I, Åsa M, Oskar S, Olle K

- - (-) - [2021-12-11; online 2021-12-11]

Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes and normal tissues

Diamanti K, Cavalli M, Pereira MJ, ..., Eriksson JW, Wadelius C

- - (-) - [2021-05-10; online 2021-05-10]

Longitudinal Assessment of 11C-5-Hydroxytryptophan Uptake in Pancreas After Debut of Type 1 Diabetes.

Espes D, Carlsson PO, Selvaraju RK, ..., Korsgren O, Eriksson O

Diabetes 70 (4) 966-975 [2021-04-00; online 2021-01-21]

Daniel Espes Olof Eriksson SciLifeLab Fellow

In Vivo Visualization of β-Cells by Targeting of GPR44.

Eriksson O, Johnström P, Cselenyi Z, ..., Skrtic S, Korsgren O

Diabetes 67 (2) 182-192 [2018-02-00; online 2017-12-05]

Olof Eriksson SciLifeLab Fellow